ANA Ananda Pharma Plc

31 October 2024

Ananda Developments plc

("Ananda Developments" or the "Company")

Total Voting Rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, Ananda announces that the Company has 4,256,289,439 ordinary shares of 0.2p each in issue ("Ordinary Shares"), each share carrying the right to one vote.

This figure of 4,256,289,439 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

To stay up to date with the latest developments at Ananda, we encourage you to follow and join our social media channels which are:  

·      Register at our Investor Hub: https://investors.anandadevelopments.com/s/a66906

·      Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=

·      LinkedIn: https://www.linkedin.com/company/anadevelopments/

·      Twitter: https://twitter.com/AnandaPlc

·     Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor

​

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

About Ananda Developments

Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions

For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/s/a66906.

https://investors.anandadevelopments.com/link/XyOYwr